Categories
Panome Bio
About CRO
Panome Bio, a leading CRO based in St. Louis, MO (4340 Duncan Ave), specializes in multi-omics services, including metabolomics, proteomics, and transcriptomics, to drive biomarker discovery and drug development. Panome Bio uses its Next-Generation Metabolomics™ platform and LC/MS technology to deliver actionable insights for biotech and pharma research, supporting preclinical and clinical studies in cancer, aging, and drug metabolism.
Why Choose Panome Bio?
- Multi-Omics Integration: We combine metabolomics, proteomics, and transcriptomics for comprehensive biological insights.
- Precision & Scale: We deliver reliable data with high-throughput assays and computational pipelines.
- Collaborative Approach: We provide tailored experiments and data reports, with 4-6 week delivery.
- Innovative Platforms: We pioneer Next-Generation Metabolomics™ and phosphoproteomics for novel biomarkers.
Technology & Expertise
Panome Bio is a next-generation multi-omics CRO specializing in metabolomics, phosphoproteomics, and lipidomics. Using advanced mass spectrometry and proprietary analytics, they deliver deep insights into thousands of metabolites, proteins, and phosphosites. Our platform supports high-throughput studies, pathway discovery, and multi-omics integration, helping researchers uncover novel biology with speed and precision.
Core Services
Untargeted Metabolomics Service. Global Phosphoproteomics Service. RNA sequencing services ● Untargeted Proteomics Service. Targeted Proteomics Assays. Targeted Metabolomics Assays . Metabolic Flux Analysis . Untargeted Metabolomics for FFPE Samples (Formalin-fixed Paraffin-embedded) . Multi-omic data analysis and integration
Accreditations & Compliance
CLIA Certified, Panome Bio follows strict quality control and data security protocols
